Altmetric

Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance

File Description SizeFormat 
Adams ONCOLREP 2015.pdfPublished version745.64 kBAdobe PDFView/Open
Title: Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance
Authors: Adams, C
Cazzanelli, G
Rasul, S
Hitchinson, B
Hu, Y
Coombes, RC
Raguz, S
Yaguee, E
Item Type: Journal Article
Issue Date: 19-May-2015
Date of Acceptance: 23-Mar-2015
URI: http://hdl.handle.net/10044/1/31694
DOI: http://dx.doi.org/10.3892/or.2015.3988
ISSN: 1021-335X
Publisher: Spandidos Publications
Start Page: 415
End Page: 422
Journal / Book Title: Oncology Reports
Volume: 34
Issue: 1
Copyright Statement: Published in Oncology Reports 34: 415-422 by Spandidos Publications 2015
Sponsor/Funder: Cancer Research UK
Breast Cancer Research Trust
Breast Cancer Campaign
Cancer Research UK
Funder's Grant Number: C37/A11680
N/A
2011MaySP01
C1312/A15589
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
inhibitors of apoptosis
drug resistance
doxorubicin
caspases
estrogen
tamoxifen
BREAST-CANCER CELLS
THERAPEUTIC TARGET
GENE-EXPRESSION
PROTEINS
P53
TUMORIGENESIS
PATHWAY
IAPS
Antibiotics, Antineoplastic
Apoptosis
Breast Neoplasms
Caspase 9
Cell Line, Tumor
Cell Proliferation
Doxorubicin
Drug Resistance, Neoplasm
Female
Humans
Intracellular Signaling Peptides and Proteins
MCF-7 Cells
RNA, Small Interfering
Up-Regulation
1112 Oncology And Carcinogenesis
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons